UW researchers develop RSV vaccine; human trials underway

Canada News News

UW researchers develop RSV vaccine; human trials underway
Canada Latest News,Canada Headlines
  • 📰 fox13seattle
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 59%

University of Washington researchers have developed a vaccine for respiratory syncytial virus, which is commonly known as RSV. FOX13

The vaccine is undergoing testing in human clinical trials.

" is marching forward in clinical development," said Neil King, whose UW Medicine lab in the UW Medicine Institute for Protein Design pioneered the vaccine nanoparticle technology.Health experts said the virus is spreading rapidly across the nation and in Washington. Its symptoms mimic a common cold that people can treat themselves. However, it can become very severe for those with compromised immune systems and those who are elderly.

UW said the vaccine showed promise in Phase 1 trial results published earlier this year. A new trial is testing a slightly altered version of the shot in the form of a bivalent vaccine against both RSV and human metapneumovirus . Older adults are enrolled to receive the bivalent vaccine in the current trial. Initial results are expected in mid-2023. that I have read and agree

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

fox13seattle /  🏆 328. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

RSV Is Bad. Where's the Vaccine? - The Journal. - WSJ PodcastsRSV Is Bad. Where's the Vaccine? - The Journal. - WSJ PodcastsEvery winter, the respiratory virus RSV lands tens of thousands of babies and young children in hospitals around the country. This year, the outbreak started early. WSJ's Denise Roland explains the challenges of creating an RSV vaccine. Further Reading: -GSK Poised for Pfizer Battle in RSV Vaccine Market -RSV Hospitalizations Surge, Babies Hit Hardest
Read more »

California child dies of flu and RSV as cases soar, hospitals threatenedCalifornia child dies of flu and RSV as cases soar, hospitals threatenedThe California Department of Public Health reported the season’s first death of a child under 5 due to flu and respiratory syncytial virus, or RSV.
Read more »

California announces 1st death this year of a child under 5 from RSV and fluCalifornia announces 1st death this year of a child under 5 from RSV and fluAs both influenza and RSV surge throughout the country this year, California is reporting its first death this year of a child under age 5 from the two viruses.
Read more »

Covid-19 vaccination does not increase risk of RSV infectionCovid-19 vaccination does not increase risk of RSV infectionSocial media posts claim Pfizer and Moderna's clinical trial results show their Covid-19 shots put children at greater risk of contracting respiratory syncytial virus (RSV). This is false; experts say the allegation is a misinterpretation of the data, no such risk has been identified at a population level, and infant and toddler vaccination rates are too low to correlate with the uptick of RSV cases in Canada and the US.
Read more »

California announces 1st death this year of a child under 5 from RSV and fluCalifornia announces 1st death this year of a child under 5 from RSV and fluAs both influenza and RSV surge throughout the country this year, California is reporting its first death this year of a child under age 5 from the two viruses.
Read more »

RSV: California reports first child death due to flu and Respiratory Syncytial VirusRSV: California reports first child death due to flu and Respiratory Syncytial VirusThis comes two weeks after Orange County declared a local health emergency due to record numbers of pediatric hospitalizations and daily emergency room visits over rapidly-spreading viral infections.
Read more »



Render Time: 2025-02-28 23:51:22